PL3348307T3 - Kompozycja zawierająca karnitynę, cholan sodu, octan sodu i ewentualnie srebro do zastosowania w leczeniu łuszczycy - Google Patents
Kompozycja zawierająca karnitynę, cholan sodu, octan sodu i ewentualnie srebro do zastosowania w leczeniu łuszczycyInfo
- Publication number
- PL3348307T3 PL3348307T3 PL18151315T PL18151315T PL3348307T3 PL 3348307 T3 PL3348307 T3 PL 3348307T3 PL 18151315 T PL18151315 T PL 18151315T PL 18151315 T PL18151315 T PL 18151315T PL 3348307 T3 PL3348307 T3 PL 3348307T3
- Authority
- PL
- Poland
- Prior art keywords
- carnitine
- psoriasis
- treatment
- composition
- sodium
- Prior art date
Links
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 title 1
- 201000004681 Psoriasis Diseases 0.000 title 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 title 1
- 229960004203 carnitine Drugs 0.000 title 1
- 229910052709 silver Inorganic materials 0.000 title 1
- 239000004332 silver Substances 0.000 title 1
- 235000017281 sodium acetate Nutrition 0.000 title 1
- 239000001632 sodium acetate Substances 0.000 title 1
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102017000004019A IT201700004019A1 (it) | 2017-01-16 | 2017-01-16 | Composizione comprendente carnitina, colato di sodio, acetato di sodio ed eventualmente argento per uso nel trattamento di psoriasi, vitiligine e rosacea |
| EP18151315.1A EP3348307B1 (en) | 2017-01-16 | 2018-01-12 | Composition comprising carnitine, sodium cholate, sodium acetate and optionally silver for use in the treatment of psoriasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3348307T3 true PL3348307T3 (pl) | 2022-05-16 |
Family
ID=58995037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18151315T PL3348307T3 (pl) | 2017-01-16 | 2018-01-12 | Kompozycja zawierająca karnitynę, cholan sodu, octan sodu i ewentualnie srebro do zastosowania w leczeniu łuszczycy |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20180200297A1 (pl) |
| EP (1) | EP3348307B1 (pl) |
| DK (1) | DK3348307T3 (pl) |
| ES (1) | ES2910949T3 (pl) |
| IT (1) | IT201700004019A1 (pl) |
| MA (1) | MA44742A (pl) |
| PL (1) | PL3348307T3 (pl) |
| PT (1) | PT3348307T (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7165534B2 (ja) * | 2018-08-09 | 2022-11-04 | 花王株式会社 | 白斑の予防又は改善剤 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19522694A1 (de) * | 1995-06-22 | 1997-01-02 | Vinas Jose Maria De Moragas | Teerhaltige Zusammensetzung und diese enthaltende pharmazeutische und kosmetische Zubereitung |
| DE10133200A1 (de) * | 2001-07-07 | 2003-01-23 | Beiersdorf Ag | Carnitin enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut |
| FR2850276B1 (fr) | 2003-01-23 | 2005-03-04 | Louis Gerald Alcindor | Composition anti-exsudante et/ou anti-desquamante et/ou anti-exfoliante |
| DE102006021198B4 (de) * | 2006-05-06 | 2008-01-17 | Stüttgen, Dieter, Dipl.-Chem. | Dermale Anwendung konzentrierter wässriger Lösungen aus Natriumchlorid oder anderen nicht giftigen anorganischen oder organischen Natriumsalzen als Mittel gegen die Hautkrankheit Vitiligo |
| HUP1300647A2 (hu) * | 2013-11-12 | 2015-05-28 | Druggability Technologies Ip Holdco Jersey Ltd | Ciklosporin A és származékainak komplexei, elõállításuk és gyógyszerészeti kompozícióik |
| PL2946765T3 (pl) * | 2014-05-23 | 2017-08-31 | Ares Trading S.A. | Ciekła kompozycja farmaceutyczna |
-
2017
- 2017-01-16 IT IT102017000004019A patent/IT201700004019A1/it unknown
-
2018
- 2018-01-12 PL PL18151315T patent/PL3348307T3/pl unknown
- 2018-01-12 DK DK18151315.1T patent/DK3348307T3/da active
- 2018-01-12 PT PT181513151T patent/PT3348307T/pt unknown
- 2018-01-12 US US15/869,147 patent/US20180200297A1/en not_active Abandoned
- 2018-01-12 ES ES18151315T patent/ES2910949T3/es active Active
- 2018-01-12 EP EP18151315.1A patent/EP3348307B1/en active Active
- 2018-01-12 MA MA044742A patent/MA44742A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA44742A (fr) | 2019-02-27 |
| EP3348307A1 (en) | 2018-07-18 |
| US20180200297A1 (en) | 2018-07-19 |
| ES2910949T3 (es) | 2022-05-17 |
| PT3348307T (pt) | 2022-04-04 |
| EP3348307B1 (en) | 2022-03-02 |
| DK3348307T3 (da) | 2022-03-14 |
| IT201700004019A1 (it) | 2018-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL256085B (en) | A converted derivative of huanic acid, a pharmaceutical preparation containing it and the converted derivative for use in treatment | |
| GB2548873B (en) | Use of Cannabidiol in the Treatment of SturgeWeber Syndrome | |
| SI3675854T1 (sl) | Derivati piperidinil-indola za uporabo v zdravljenju glomerulopatije c3 | |
| EP3250609A4 (en) | Il13ra alpha 2 binding agents and use thereof in cancer treatment | |
| IL258246B (en) | Isolidine compound, pharmaceutical compositions comprising same, their combinations with therapeutic agents for use in the treatment of cancer | |
| GB201511382D0 (en) | Novel compounds and their use in therapy | |
| EP3267989A4 (en) | Fixed dose combinations and formulations comprising etc1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease | |
| GB201820659D0 (en) | Novel compostions and their use in therapy | |
| PL3732294T3 (pl) | Tymohydrochinon do stosowania w leczeniu hiperglikemii | |
| CA3292080A1 (en) | Formulations of milciclib and therapeutic combinations of the same for use in the treatment of cancer | |
| DK3383872T3 (da) | 1,3,4-thiadiazolforbindelser og anvendelse deraf i cancerbehandling | |
| PL3331610T3 (pl) | Środki do zastosowania w leczeniu glejaka | |
| EP3266865A4 (en) | Cell therapeutic agent for cancer treatment and combination therapy with same | |
| EP3344233A4 (en) | TRANSDERMAL FORMULATIONS FOR THE DELIVERY OF DOXYCLYCLIN AND THEIR USE IN THE TREATMENT OF DOXYCLYCLIN-RELATED ILLNESSES AND SUFFERING | |
| IL274363A (en) | Use of a specific siRNA against protein S for the treatment of hemophilia | |
| EP3380468B8 (en) | Bis-pyridazine compounds and their use in treating cancer | |
| GB201514015D0 (en) | Novel pyridazinones and their use in the treatment of cancer | |
| IL280389A (en) | Bile acid receptor modulators conjugated to G.1 protein and methods of using them | |
| ZA202006886B (en) | R-fadrozole for use in the treatment of aldostonerism | |
| PL3325478T3 (pl) | Nowy związek terapeutyczny i zastosowanie w terapii | |
| IL269121A (en) | Usl-311 for use in the treatment of cancer | |
| SG11202103070VA (en) | Donecopride as neuroprotective agent in the treatment of neurodegenerative diseases | |
| EP3208262A4 (en) | Compounds derived from 3-alkylamino-1h-indole acrylate, and the use thereof in the treatment of neurodegenerative diseases | |
| EP3648789C0 (en) | MTMR2-S POLYPEPTIDE FOR USE IN THE TREATMENT OF MYOPATHY | |
| PT3348307T (pt) | Composição que compreende carnitina, colato de sódio, acetato de sódio e opcionalmente prata para utilização no tratamento de psoríase |